Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (8)
  • 2025 (5)

Subject

  • Drug Trafficking (75)
  • Synthetic drugs (32)
  • Arrests/Convictions - Major (24)
  • Guns/Weapons (23)
  • Seizures (Drugs/Property) (22)
  • Fake Pills (21)
  • Prescription Drugs (19)
  • Fentanyl Awareness (18)
  • Major Law Enforcement Operation (12)
  • Fentanyl Free America (8)
  • Take Back Day (8)
  • Diversion Division (7)
  • Guilty Plea (7)
  • Money Laundering (6)
  • Overdose (6)
  • Counterfeit Pills (5)
  • OCDETF/Task Force (5)
  • Outreach/Drug Prevention (5)
  • Cartel (4)
  • Gangs (4)
  • Other (4)
  • Campaigns (3)
  • Extraditions (3)
  • Narcoterrorism (3)
  • Task Forces/Task Force Officers (3)
  • International/Foreign Operations (2)
  • One Pill Can Kill (2)
  • Dark Web- Internet Trafficking (1)
  • Press Conferences (1)
  • Prevention/Education - DEA websites GSAD, JTT etc (1)
  • Public and Media Affairs - also see Congressional Affairs (1)
  • Pharmaceuticals/Pharmacists/Physicians (13)

Drug Name

  • Benzodiazepines (1)
  • Fentanyl (1)
  • Hydromorphone (1)
  • Morphine (1)
  • Opioids (1)
  • Oxycodone (1)

Field Division

  • Atlanta (3)
  • Caribe (1)
  • El Paso (5)
  • Louisville (8)
  • Miami (4)
  • New England (1)
  • New Jersey (2)
  • New York (4)
  • Omaha (2)
  • Phoenix (2)
  • Rocky Mountain (1)
  • San Francisco (5)
  • Seattle (3)
  • Sede (3)
  • St. Louis (7)
  • Tampa (1)
  • Washington, DC (1)
Clear All Results
View Archived Press Releases
13 Results - Showing 1 to 10
PRESS RELEASE

United States Reaches $4.17 Million Civil Settlement and Three-Year Compliance Agreement with West Virginia University Health System Over Controlled Substance Violations

WHEELING, Wv. — The United States Attorney’s Offices for the Northern and Southern Districts of West Virginia announced today that West Virginia United Health System, Inc., doing business as West Virginia University Health System (WVUHS), has agreed to pay $4,177,139 and enter a Memorandum of Agreement to resolve civil allegations...
PRESS RELEASE

Former Albuquerque Dentist Ordered to Pay $320,000 for Violating Controlled Substances and False Claims Acts

ALBUQUERQUE – The DEA and the U.S. Attorney's Office announced today that a federal court has entered a $320,000.00 judgment against a former Albuquerque dentist to resolve allegations that he violated the Controlled Substances Act (CSA) by unlawfully issuing prescriptions after his professional licenses were revoked or expired. William C...
PRESS RELEASE

Northern District of West Virginia Part of National Health Care Fraud Takedown Resulting in 455 Defendants Charged in Connection with Over $6.5 Billion in Alleged Fraud

WHEELING, WEST VIRGINIA - Today, United States Attorney Matthew L. Harvey announced civil settlements with two defendants in connection with alleged schemes to defraud Medicare and Medicaid. The civil settlements are part of the Department of Justice’s 2026 National Health Care Fraud Takedown. The settlements stem from each defendant’s respective...
PRESS RELEASE

DEA El Paso and Partners Remove 4,796 Pounds of Unused Medications from Communities in West Texas and New Mexico

El Paso, Texas – DEA and its local law enforcement partners collected 4,796 pounds of unused medications during the 30th National Prescription Drug Take Back Day on April 25, 2026. “I had the pleasure of visiting multiple locations in El Paso and saw the overwhelming response from our community,” said...
PRESS RELEASE

United States Files Civil Complaint Against New Mexico Psychologist Alleging Improper Prescribing of Controlled Substances

Note: View the Civil Complaint ALBUQUERQUE – The United States has filed a civil complaint in federal court alleging that a New Mexico psychologist unlawfully prescribed controlled substances without a legitimate medical purpose, in violation of the Controlled Substances Act. In a complaint filed in federal court, the United States...
PRESS RELEASE

DEA issues Immediate Suspension Orders to a Tennessee pharmacy over Controlled Substances Act violations

LOUISVILLE, Ky. – Earlier today, the U.S. Drug Enforcement Administration issued an Immediate Suspension Orders (ISO) to A + Pharmacy, a retail drug store located in Chattanooga, Tennessee. An ISO is an emergency administrative action that immediately suspends a DEA registrant's authority to handle controlled substances, due to imminent danger...
PRESS RELEASE

DEA Issues Immediate Suspension Order to Kentucky Pharmaceutical Distributor Over Controlled Substances Act Violations

LOUISVILLE, Ky. – Earlier today, the U.S. Drug Enforcement Administration issued an Immediate Suspension Order (ISO) to Richie Pharmacal, a pharmaceutical distributor in Glasgow, Kentucky. An ISO is an emergency administrative action that immediately suspends a DEA registrant's authority to handle controlled substances, due to imminent danger to public health...
PRESS RELEASE

El Paso Doctor Enters $200,000 Settlement Following State and Federal Fraud Allegations

EL PASO, Texas – Dr. Brian August, located in El Paso, has agreed to pay $200,000 to resolve allegations that he violated the Controlled Substances Act, the False Claims Act, and the Texas Health Care Program Fraud Prevention Act. The allegations involved the issuance of 255 controlled substance prescriptions to...
PRESS RELEASE

Southern New Mexico Medical Spa Operator Settles Allegations of Controlled-Substance Recordkeeping Violations

Note: View the Settlement Agreement ALBUQUERQUE – The United States has reached a civil settlement with Luis Carlos Cordova, operator of Limitless Aesthetics and Healthcare in Santa Teresa, New Mexico, to resolve allegations that he failed to meet federal controlled-substance recordkeeping requirements under the Controlled Substances Act. According to the...
PRESS RELEASE

Clay County Pharmacy Investigation and Prosecution Ends in Guilty Pleas

NASHVILLE – Thomas K. Weir, 65, majority owner of Oakley Pharmacy d/b/a Dale Hollow Pharmacy and Clay County Xpress Pharmacy (“Xpress Pharmacy”); William L. Donaldson, 65, former owner and pharmacist of Dale Hollow Pharmacy (then known as Donaldson Pharmacy); and Pamela Spivey, 55, co-owner of Xpress Pharmacy (all of Celina...

Paginación

  • Current page 1
  • Page 2
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster